Stock ANRO ALTO NEUROSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Alto Neuroscience, Inc.

Equities

ANRO

US02157Q1094

Market Closed - Nyse
Other stock markets
 16:00:03 2024-06-21 EDT 		5-day change 1st Jan Change
11 USD -0.45% Intraday chart for Alto Neuroscience, Inc. -8.56% 0.00%
06-20 Alto Neuroscience, Inc. Initiates Phase 2 Study of ALTO-101, Novel PDE4 Inhibitor, in Cognitive Impairment Associated with Schizophrenia CI
05-21 Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANRO Stock
  4. News Alto Neuroscience, Inc.
  5. Transcripts